2013年糖尿病重要临床进展回顾

Review of important clinical advances in diabetes mellitus in 2013

在过去的2013年,美国糖尿病学会（ADA）、美国内分泌医师协会（AACE）及中华医学会内分泌学分会等组织,针对糖尿病的临床诊治、综合管理及减重对并发症的影响等颁布了一些指南和共识或新的看法;关于糖尿病患者血压控制目标第8届美国国家联合委员会（JNC8）也有新的指南发布;同时,对于几种降糖药物的安全性问题,美国食品与药品管理局（FDA）也发布了声明.这些对于规范临床诊治及用药有重要意义.

In the past 2013,American Diabetes Association （ADA）,American Association of Clinical Endocrinologists（AACE）,Chinese Society of Endocrinology,etc.published some guidelines and consensuses on topics such as clinical diagnnsis,treatment,integrated management,and the relationship between reducing body weight and complications.Characters of blood pressure control in diabetic patients were also announced by the Eighth Joint National Committee （JNC 8）.Meanwhile,Food and Drug Administration （FDA） declared the statements on safety of several hypoglycemic agents.These guidelines and consensuses will play key roles in standardizing clinical diagnosis,treatment,and medication.